Incannex Healthcare stock tumbles after filing $100M offering
MINNEAPOLIS - Tactile Systems Technology, Inc. (NASDAQ:TCMD) reported fourth quarter earnings that beat analyst estimates, but shares plunged 11.20% after the company provided disappointing guidance for 2025.
The medical technology company posted adjusted earnings per share of $0.40 for Q4, surpassing the consensus estimate of $0.31. Revenue grew 10% year-over-year to $85.6 million, slightly ahead of expectations of $85.41 million.
For the full year 2024, Tactile Systems reported revenue of $293.0 million, up 7% compared to 2023. Adjusted EBITDA increased to $37.1 million from $29.7 million the previous year.
However, the company’s outlook for 2025 fell short of analyst projections. Tactile Systems expects full year 2025 revenue between $316 million and $322 million, representing growth of 8% to 10% YoY. It also forecasts adjusted EBITDA of $35 million to $37 million, down from $37.1 million in 2024.
"Our fourth quarter results capped off a dynamic year for Tactile, during which we launched our next-generation lymphedema platform, generated clinical evidence supporting the value of our therapies, deployed new workflow-related tools to enhance speed and efficiency in order operations, and served over 79,000 patients with our lymphedema and airway clearance solutions," said CEO Sheri Dodd.
The company ended 2024 with $94.4 million in cash, up from $61.0 million at the end of 2023. Tactile Systems also has $26.5 million remaining under its $30 million share repurchase program.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.